BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 35563060)

  • 1. Role of Glycogen Synthase Kinase-3 in Interferon-γ-Mediated Immune Hepatitis.
    Chen CL; Tseng PC; Satria RD; Nguyen TT; Tsai CC; Lin CF
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycogen synthase kinase-3β indirectly facilitates interferon-γ-induced nuclear factor-κB activation and nitric oxide biosynthesis.
    Kai JI; Huang WC; Tsai CC; Chang WT; Chen CL; Lin CF
    J Cell Biochem; 2010 Dec; 111(6):1522-30. PubMed ID: 20872791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycogen Synthase Kinase-3β (GSK-3β) Inhibition Enhances Dendritic Cell-based Cancer Vaccine Potency via Suppression of Interferon-γ-induced Indoleamine 2,3-Dioxygenase Expression.
    Noh KT; Son KH; Jung ID; Kang TH; Choi CH; Park YM
    J Biol Chem; 2015 May; 290(19):12394-402. PubMed ID: 25814664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycogen synthase kinase-3 facilitates con a-induced IFN-γ-- mediated immune hepatic injury.
    Tsai CC; Huang WC; Chen CL; Hsieh CY; Lin YS; Chen SH; Yang KC; Lin CF
    J Immunol; 2011 Oct; 187(7):3867-77. PubMed ID: 21873526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mood stabilizing properties of AF3581, a novel potent GSK-3β inhibitor.
    Capurro V; Lanfranco M; Summa M; Porceddu PF; Ciampoli M; Margaroli N; Durando L; Garrone B; Ombrato R; Tongiani S; Reggiani A
    Biomed Pharmacother; 2020 Aug; 128():110249. PubMed ID: 32470749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulation of glycogen synthase kinase-3beta signaling in hepatocellular carcinoma cells.
    Desbois-Mouthon C; Blivet-Van Eggelpoël MJ; Beurel E; Boissan M; Delélo R; Cadoret A; Capeau J
    Hepatology; 2002 Dec; 36(6):1528-36. PubMed ID: 12447879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycogen synthase kinase-3beta facilitates IFN-gamma-induced STAT1 activation by regulating Src homology-2 domain-containing phosphatase 2.
    Tsai CC; Kai JI; Huang WC; Wang CY; Wang Y; Chen CL; Fang YT; Lin YS; Anderson R; Chen SH; Tsao CW; Lin CF
    J Immunol; 2009 Jul; 183(2):856-64. PubMed ID: 19542364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IFN-gamma synergizes with LPS to induce nitric oxide biosynthesis through glycogen synthase kinase-3-inhibited IL-10.
    Lin CF; Tsai CC; Huang WC; Wang CY; Tseng HC; Wang Y; Kai JI; Wang SW; Cheng YL
    J Cell Biochem; 2008 Oct; 105(3):746-55. PubMed ID: 18655171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibiting glycogen synthase kinase-3 decreases 12-O-tetradecanoylphorbol-13-acetate-induced interferon-γ-mediated skin inflammation.
    Hsieh CY; Chen CL; Tsai CC; Huang WC; Tseng PC; Lin YS; Chen SH; Wong TW; Choi PC; Lin CF
    J Pharmacol Exp Ther; 2012 Oct; 343(1):125-33. PubMed ID: 22773863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new strategy for studying protein kinase B and its three isoforms. Role of protein kinase B in phosphorylating glycogen synthase kinase-3, tuberin, WNK1, and ATP citrate lyase.
    Sale EM; Hodgkinson CP; Jones NP; Sale GJ
    Biochemistry; 2006 Jan; 45(1):213-23. PubMed ID: 16388597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of SHP2 by PTEN/AKT/GSK-3β signaling facilitates IFN-γ resistance in hyperproliferating gastric cancer.
    Tseng PC; Huang WC; Chen CL; Sheu BS; Shan YS; Tsai CC; Wang CY; Chen SO; Hsieh CY; Lin CF
    Immunobiology; 2012 Sep; 217(9):926-34. PubMed ID: 22325465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue-specific role of glycogen synthase kinase 3beta in glucose homeostasis and insulin action.
    Patel S; Doble BW; MacAulay K; Sinclair EM; Drucker DJ; Woodgett JR
    Mol Cell Biol; 2008 Oct; 28(20):6314-28. PubMed ID: 18694957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An increase in galectin-3 causes cellular unresponsiveness to IFN-γ-induced signal transduction and growth inhibition in gastric cancer cells.
    Tseng PC; Chen CL; Shan YS; Lin CF
    Oncotarget; 2016 Mar; 7(12):15150-60. PubMed ID: 26934444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Convergence of multiple signaling cascades at glycogen synthase kinase 3: Edg receptor-mediated phosphorylation and inactivation by lysophosphatidic acid through a protein kinase C-dependent intracellular pathway.
    Fang X; Yu S; Tanyi JL; Lu Y; Woodgett JR; Mills GB
    Mol Cell Biol; 2002 Apr; 22(7):2099-110. PubMed ID: 11884598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistin disrupts glycogen synthesis under high insulin and high glucose levels by down-regulating the hepatic levels of GSK3β.
    Song R; Wang X; Mao Y; Li H; Li Z; Xu W; Wang R; Guo T; Jin L; Zhang X; Zhang Y; Zhou N; Hu R; Jia J; Lei Z; Irwin DM; Niu G; Tan H
    Gene; 2013 Oct; 529(1):50-6. PubMed ID: 23860320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silencing glycogen synthase kinase-3beta inhibits acetaminophen hepatotoxicity and attenuates JNK activation and loss of glutamate cysteine ligase and myeloid cell leukemia sequence 1.
    Shinohara M; Ybanez MD; Win S; Than TA; Jain S; Gaarde WA; Han D; Kaplowitz N
    J Biol Chem; 2010 Mar; 285(11):8244-55. PubMed ID: 20061376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of glycogen synthase kinase 3beta in insulin-stimulated glucose metabolism.
    Summers SA; Kao AW; Kohn AD; Backus GS; Roth RA; Pessin JE; Birnbaum MJ
    J Biol Chem; 1999 Jun; 274(25):17934-40. PubMed ID: 10364240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycogen synthase kinase-3beta is involved in the process of myocardial hypertrophy stimulated by insulin-like growth factor-1.
    Seimi SK; Seinosuke K; Tsuyoshi S; Tomomi U; Tetsuaki H; Miki K; Ryuji T; Kenji I; Mitsuhiro Y
    Circ J; 2004 Mar; 68(3):247-53. PubMed ID: 14993781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycogen synthase kinase 3beta-mediated apoptosis of primary cortical astrocytes involves inhibition of nuclear factor kappaB signaling.
    Sanchez JF; Sniderhan LF; Williamson AL; Fan S; Chakraborty-Sett S; Maggirwar SB
    Mol Cell Biol; 2003 Jul; 23(13):4649-62. PubMed ID: 12808104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivation of glycogen synthase kinase-3β is required for osteoclast differentiation.
    Jang HD; Shin JH; Park DR; Hong JH; Yoon K; Ko R; Ko CY; Kim HS; Jeong D; Kim N; Lee SY
    J Biol Chem; 2011 Nov; 286(45):39043-50. PubMed ID: 21949120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.